Dayzz Sleep App Announces Publication of the Findings From Clinical Trial to Validate Its Sleep Assessment Machine Learning Engine

TEL AVIV, Israel, June 25, 2020 /PRNewswire/ — Innovative sleep solution provider dayzz announced this week the results of its first clinical trial. dayzz’ machine learning engine enables assessment of common sleep disturbances using a proprietary questionnaire. The clinical trial was conducted in collaboration with the Johns Hopkins Center for Interdisciplinary Sleep Research and Education.

In the U.S., more than 30% of the adult population suffer from sleep problems, and it is estimated that 50-70 million Americans have a sleep disorder that affects their health and quality of life. Many of them are undiagnosed and untreated. Insufficient sleep alone costs the US economy over $400 billion a year, and sleep problems among employees have huge financial implications on employers and payers. dayzz has developed and validated the Digital Sleep Questionnaire (DSQ) to identify common societal sleep disturbances including insomnia, delayed sleep phase syndrome, insufficient sleep syndrome, and risk for obstructive sleep apnea.

“dayzz’ machine learning algorithm was trained on gold-standard sleep expert diagnoses of people in the community with common sleep complaints and has shown high accuracy in predicting those at risk for prevalent sleep disorders,” said Dr. Mairav Cohen-Zion, Chief Science Officer at dayzz. “This is a critical step forward for dayzz in identifying sleep disorders at scale and offering a personalized sleep training experience for our users.”

In the upcoming months, dayzz will launch a randomized clinical trial in collaboration with researchers at Brigham and Women’s Hospital and Harvard Medical School to examine the effectiveness of its solution in a large community-based organizational setting.

Read in Sleep Medicine the scientific paper.

About dayzz

dayzz is an innovative digital sleep solution, providing personalized sleep training plans to individuals across the US. dayzz’ machine learning engine enables assessment of common sleep problems. Based on big data analysis, the app constantly adjusts users’ training plans to fit their needs and progress, and offers the right intervention at the right time, with continuous support and unique motivational strategies. dayzz offers its sleep solution to US employers and payers to increase productivity, enhance well-being, optimize usage of the healthcare system and reduce associated costs. Based on the vast amounts of data gathered, employers receive periodic overview reports, presenting aggregated data about their employees’ sleep status to help them better understand how to further improve employee experience and performance. The company is led by an experienced team in the fields of business, technology, and clinical treatment. For more information, visit https://dayzz.com.

Media Contact
Gal Yankovitz
dayzz
galy@dayzz.com

View original content:http://www.prnewswire.com/news-releases/dayzz-sleep-app-announces-publication-of-the-findings-from-clinical-trial-to-validate-its-sleep-assessment-machine-learning-engine-301083677.html

SOURCE dayzz

Staff

Recent Posts

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2024 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 18, 2024) - Medexus Pharmaceuticals (TSX: MDP)…

8 hours ago

InsiteOne Achieves Strong Growth with Six New Contracts Post Acquisition of BRIT Systems Cloud-Native RIS/PACS/VNA

WALLINGFORD, Conn., June 18, 2024 /PRNewswire/ -- InsiteOne, a leading provider of cloud-based Vendor Neutral Archive…

8 hours ago

Young Women’s Christian Association of Bethlehem PA Completes its Investigation of Security Incident

BETHLEHEM, Pa., June 18, 2024 /PRNewswire/ -- Young Women's Christian Association of Bethlehem PA ("YWCA…

8 hours ago

INSIGHTEC ANNOUNCES $150M FINANCING TO FUND CONTINUED GROWTH

Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead…

8 hours ago

IntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry’s Best-in-Class Commercial Data Solution

Combined entity delivers the ICyte® revenue optimization platform powered by first-party data, AI-enabled data exploration,…

8 hours ago

WellBe Senior Medical Earns HITRUST & NIST Certification, Highlighting Commitment to Data Security

CHICAGO, June 18, 2024 /PRNewswire/ -- WellBe Senior Medical and its affiliated medical groups announce…

8 hours ago